|
CSNK2A1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.824850E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.987800E-02 |
| Normal-vs-Stage2 |
1.811580E-01 |
| Normal-vs-Stage3 |
1.246570E-04 |
| Normal-vs-Stage4 |
2.609900E-02 |
| Stage1-vs-Stage2 |
8.120400E-01 |
| Stage1-vs-Stage3 |
6.499200E-03 |
| Stage1-vs-Stage4 |
2.995200E-01 |
| Stage2-vs-Stage3 |
1.379640E-01 |
| Stage2-vs-Stage4 |
5.695400E-01 |
| Stage3-vs-Stage4 |
3.591800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.443900E-03 |
| Normal-vs-AfricanAmerican |
3.57710000000733E-05 |
| Normal-vs-Asian |
5.989000E-01 |
| Caucasian-vs-AfricanAmerican |
9.063800E-03 |
| Caucasian-vs-Asian |
7.569000E-01 |
| AfricanAmerican-vs-Asian |
1.561380E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.883310E-03 |
| Normal-vs-Female |
1.698150E-02 |
| Male-vs-Female |
4.954200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.880000E-01 |
| Normal-vs-Age(41-60Yrs) |
4.547600E-02 |
| Normal-vs-Age(61-80Yrs) |
8.840000E-04 |
| Normal-vs-Age(81-100Yrs) |
1.629570E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.315400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.786400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.196800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.533240E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.203790E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.067000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.301200E-01 |
| Normal-vs-Grade 2 |
6.204500E-02 |
| Normal-vs-Grade 3 |
5.560800E-04 |
| Normal-vs-Grade 4 |
2.639000E-03 |
| Grade 1-vs-Grade 2 |
8.894000E-01 |
| Grade 1-vs-Grade 3 |
4.333400E-01 |
| Grade 1-vs-Grade 4 |
3.292400E-01 |
| Grade 2-vs-Grade 3 |
6.847500E-02 |
| Grade 2-vs-Grade 4 |
5.899500E-02 |
| Grade 3-vs-Grade 4 |
5.563400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.000360E-01 |
| Normal-vs-ccB subtype |
1.487030E-01 |
| ccA subtype-vs-ccB subtype |
9.996000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.214590E-01 |
| Normal-vs-N1 |
7.881400E-01 |
| N0-vs-N1 |
8.220800E-01 |
|
|
